Bhutan, Maldives first among 6 recipients of Covid vaccine from India
Bhutan, Maldives first among 6 recipients of Covid vaccine from India
Bhutan is the first country to receive the Government of India s (GoI) gift of the Covidshield vaccine, manufactured by the Serum Institute of India (SII), on Wednesday, followed by Maldives the same day.
advertisement
Prime Minister Narendra Modi has called the move Vaccine Maitri . (Photo: India Today / PTI)
Even in the pandemic, India stayed with her neighbourhood first policy and chose Maldives and Bhutan as the first two countries to be provided with Covid-19 vaccines, that will be delivered today (January 20).
URL copied Image Source : AP
India s vaccination drive: 3,81,305 people jabbed; 2 post-vaccination deaths in UP, Karnataka | Key Points
Over 3.8 lakh people have been inoculated for coronavirus in the country so far. More than 500 adverse events following immunisation were reported, accorrding to Union Health Ministry s latest data provided Monday night. The ministry also informed about two deaths in Uttar Pradesh and Karnataka post the vaccination. India on Saturday, January 16, gave the first COVID-19 vaccine shots to nearly two lakh frontline healthcare and sanitary workers as Prime Minister Narendra Modi rolled out the worldâs largest inoculation drive against the pandemic that has caused 1,52,093 deaths and upended millions of lives in the country.
Covishield: Manufacturer, dose schedule, efficacy rate, possible side effects and price
India
Updated: Saturday, January 16, 2021, 15:26 [IST]
New Delhi, Jan 16: Covishield vaccine has been developed by the University of Oxford and British-Swedish pharmaceutical company AstraZeneca.
Adar Poonawalla, Chief Executive Officer, Serum Institute of India (SII) which is British-Swedish pharma giant AstraZeneca s manufacturing partner - said that the vaccine would be 90 to 95 per cent effective if the two shots are parted by around 2-3 months.
File Photo
The vaccine is being touted as one of the most promising vaccines for India where cost and logistics play a big roll. You ll be hearing some good news from the UK very soon. It would be a 90-95 per cent effective vaccine if you just keep a two-to-three months gap between dose 1 and dose 2. They will make that public with documentation.
Dr Reddy s Lab issued a statement on Friday evening stating that they have received permission to conduct phase 3 clinical trials of Sputnik V, by the regulatory body DCGI.
What does the consent form that must be signed by Covaxin recipients say?
India
Published: Saturday, January 16, 2021, 15:29 [IST]
New Delhi, Jan 16: The consent form that must be signed by Covaxin beneficiaries states that its efficacy is yet to be established. It assures compensation by Bharat Biotech in case of a serious adverse event that is proven to be causally related to the vaccine. It further states that beneficiaries would be provided care in government-designated facilities if they suffer any adverse events.
The form read that only phase 1 and 2 trials have been completed, and that phase 3 is still on.
Representational Image